Translational medicine: The key to a thriving life science industry

January 9, 2015 Erin Righetti

In this short video, key players in the respiratory disease field in Europe look at it’s importance and how a thriving translational medicine field can help enhance the life sciences industries, public health and health life science economies. Due to the intense regulatory process that have evolved over the past few decades, this type of research is important. But often times the development life cycles and costs to bring these medications to the market are far too expensive. Barriers that hold back speedy process include low numbers of clinical trials validate these diseases and multiple protocols to conduct clinical trials in different countries.

Watch the full video here:

This March 9-11 at BIO-Europe Spring®, we’ll have a panel of experts discussing this very topic to kick off the event in the presentation Translational medicine: From discovery to early stage drug development.  For more information on the rest of the program and this year’s event, visit the webpage.

Read more...

Previous Article
ARM State of the Industry Briefing gives clear evidence that regen med/advanced therapies are the next big thing in biotech
ARM State of the Industry Briefing gives clear evidence that regen med/advanced therapies are the next big thing in biotech

Biotech Showcase™ 2015 kicked off today with the Alliance for Regenerative Medicine’s (ARM) Regenerative Me...

Next Article
Get ready for Biotech Showcase™ 2015: A preview of who is presenting

As companies prepare for Biotech Showcase next week, many are sharing what they’ll be showcasing at the eve...